V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320006499 | 320003742 | null | 74.6 | Neo-adjuvant (N) | 2017-09-25 | 2017-10-02 | TCF | 02 | Y | 320018617 | TEMOZOLOMIDE |
| 320006500 | 320003746 | 1.79 | 105 | Adjuvant (A) | 2014-05-16 | 2014-05-31 | Imatinib 400mg | 2 | null | 320018677 | CARBOPLATIN + ETOPOSIDE |
| 320006501 | 320003748 | 1.67 | 59.8 | Palliative (P) | 2015-12-13 | 2015-12-14 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | N | 320018693 | PEMBROLIZUMAB |
| 320006502 | 320006648 | 1.77 | 88.8 | Adjuvant (A) | 2016-01-02 | 2016-05-06 | Trifluridine + Tipiracil | 02 | N | 320018722 | AFLIBERCEPT + FU + IRINOTECAN |
| 320006503 | 320003751 | 1.6 | 76.1 | Palliative (P) | 2017-11-07 | 2017-11-20 | AXITINIB | N | Y | 320018760 | CISPLATIN + GEMCITABINE |
| 320006504 | 320003752 | 1.62 | null | Palliative (P) | 2017-07-07 | 2017-07-07 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320018761 | CAPECITABINE + CARBOPLATIN |
| 320006505 | 320003754 | 0 | 79.9 | Palliative (P) | 2018-12-04 | 2018-12-19 | Carboplatin + Etoposide IV 3 day | N | N | 320018773 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 320006506 | 320006650 | 1.71 | 67 | Palliative (P) | 2018-06-28 | 2018-09-03 | CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | 320018796 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320006507 | 320003755 | null | 46 | Palliative (P) | 2013-10-17 | 2013-10-20 | CARBOPLATIN + CETUXIMAB + FU | 2 | N | 320018796 | CARBOPLATIN + CETUXIMAB + FU |
| 320006508 | 320003759 | 1.85 | 80 | Palliative (P) | 2018-07-13 | 2018-07-19 | CETUXIMAB + CISPLATIN + FU | 02 | N | 320018840 | CARBOPLATIN + CETUXIMAB + FU |
| 320006509 | 320005715 | 1.8 | null | null | 2013-08-12 | 2013-08-17 | CARBOPLATIN + RT | 2 | N | 320018895 | BCG |
| 320006510 | 320003762 | 1.77 | 108.2 | Curative (C) | 2016-08-23 | 2016-09-07 | IMATINIB | N | N | 320018908 | IVA |
| 320006511 | 320003763 | 1.66 | 63 | 4 | 2014-04-24 | 2014-04-24 | Carboplatin + Etoposide IV 3 day | null | null | 320018909 | CARBOPLATIN + RT |
| 320006512 | 320003765 | 1.7 | 56 | Palliative (P) | 2014-03-20 | 2014-03-20 | CETUXIMAB + CISPLATIN + FU | 2 | N | 320018942 | TEMOZOLOMIDE |
| 320006513 | 320005719 | 1.82 | 86.2 | Not known (9) | 2015-05-14 | 2015-05-14 | CARBOPLATIN + RT | N | N | 320018943 | CARBOPLATIN + RT |
| 320006514 | 320007098 | null | 81.1 | Palliative (P) | 2015-03-24 | 2015-03-24 | CETUXIMAB + CISPLATIN + FU | 2 | N | 320019003 | EOX |
| 320006515 | 320003771 | 1.7 | 20.2 | Curative (C) | 2016-01-05 | 2016-01-21 | TEMOZOLOMIDE | 02 | N | 320019024 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320006516 | 320003772 | 1.72 | 65.8 | Palliative (P) | 2018-03-12 | 2018-03-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | Y | 320019030 | TRABECTEDIN |
| 320006517 | 320003775 | 1.71 | 80.5 | null | 2015-03-23 | 2015-03-25 | PEMBROLIZUMAB | N | N | 320019077 | CAPECITABINE + OXALIPLATIN |
| 320006518 | 320003777 | 1.78 | 76.3 | Adjuvant (A) | 2016-12-26 | 2017-01-30 | Capecitabine + Oxaliplatin 21day | N | null | 320019114 | NIVOLUMAB |
| 320006519 | 320005727 | 1.83 | null | Palliative (P) | 2016-01-22 | 2016-02-24 | Gemcitabine 1000mg/m2 D1 8 15 | null | Y | 320019172 | CAPECITABINE + CETUXIMAB + CISPLATIN |
| 320006520 | 320007100 | 1.77 | 0 | Palliative (P) | 2017-05-13 | 2017-05-31 | Carboplatin + Cetux + FU (>Cycle 2) | null | null | 320019181 | CETUXIMAB + CISPLATIN + FU |
| 320006521 | 320003782 | 1.8 | 90 | Adjuvant (A) | 2014-09-08 | 2016-02-04 | Carboplatin + Etoposide IV 3 day | N | N | 320019211 | CARBOPLATIN + RT |
| 320006522 | 320003782 | 1.81 | 80.5 | Palliative (P) | 2017-07-04 | 2017-07-10 | Irinotecan + Modified De Gramont | 02 | null | 320019211 | CISPLATIN + GEMCITABINE |
| 320006523 | 320007101 | 1.65 | 53.6 | Adjuvant (A) | 2015-04-11 | 2015-04-11 | Bevacizumab+Carbo+Pacliaxel | 01 | N | 320019230 | PEMBROLIZUMAB |
| 320006524 | 320003787 | 1.75 | 53.7 | Palliative (P) | 2017-10-15 | 2017-10-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 320019266 | CARBOPLATIN + RT |
| 320006525 | 320003790 | 1.69 | 65 | Adjuvant (A) | 2015-06-05 | 2015-06-21 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 320019296 | SUNITINIB |
| 320006526 | 320003793 | 1.75 | 106.7 | Palliative (P) | 2014-07-25 | 2014-07-25 | Carboplatin + Pemetrexed | 2 | N | 320019304 | CARBO + FLUOROURACIL |
| 320006528 | 320006667 | 1.69 | 60 | Palliative (P) | 2014-09-11 | 2014-09-18 | Cetuximab + Radiotherapy Maint | 02 | N | 320019348 | CAPECITABINE + OXALIPLATIN |
| 320006529 | 320003800 | 1.8 | 64.6 | Neo-adjuvant (N) | 2018-01-12 | 2018-03-02 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 320019389 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320006530 | 320003801 | 1.76 | 79.9 | Palliative (P) | 2014-02-24 | 2014-03-05 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 320019440 | CAPECITABINE |
| 320006531 | 320003802 | 1.73 | 67.6 | Palliative (P) | 2015-06-12 | 2015-06-13 | FLUOROURACIL + MITOMYCIN | 02 | N | 320019444 | POUT TRIAL |
| 320006532 | 320003804 | 1.63 | 19.3 | Palliative (P) | 2018-01-15 | 2018-01-15 | ICON8 TRIAL | 02 | N | 320019448 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320006533 | 320003805 | 0 | 29.1 | Curative (C) | 2017-10-15 | 2017-10-15 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 320019453 | ICON TRIAL |
| 320006534 | 320003808 | 1.56 | 68.2 | Palliative (P) | 2017-01-28 | 2017-01-28 | POMB/ACE | 02 | N | 320019455 | CAV |
| 320006535 | 320003811 | 1.71 | 78.1 | Curative (C) | 2016-01-01 | 2016-01-16 | CYCLOPHOSPHAMIDE + VINORELBINE | N | N | 320019459 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320006536 | 320003812 | 1.74 | 76.3 | Palliative (P) | 2014-03-03 | 2014-03-03 | Trifluridine + Tipiracil | N | N | 320019466 | CISPLATIN + FLUOROURACIL + RT |
| 320006537 | 320003813 | 1.8 | 69 | Palliative (P) | 2018-03-09 | 2018-03-19 | Imatinib 400mg | N | N | 320019513 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320006539 | 320005746 | null | 79 | Curative (C) | 2015-07-28 | 2015-07-30 | Cisplatin + Fluorouracil + RT 5day | N | N | 320019541 | GEMCITABINE |
| 320006540 | 320003818 | 1.75 | 79.9 | Palliative (P) | 2015-02-06 | 2015-08-01 | TEMOZOLOMIDE | 02 | N | 320019582 | CARBOPLATIN + RT |
| 320006541 | 320003819 | null | 81.1 | Palliative (P) | 2013-06-12 | 2013-09-23 | PEMBROLIZUMAB | N | N | 320019614 | NIVOLUMAB |
| 320006542 | 320003823 | 1.72 | 72 | Palliative (P) | 2015-07-11 | 2015-07-13 | BCG Intravesical | 02 | N | 320019677 | PEMBROLIZUMAB |
| 320006543 | 320005751 | 1.97 | null | Palliative (P) | 2013-12-18 | 2014-03-09 | Capecitabine + Oxaliplatin 21day | N | N | 320019712 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320006545 | 320003826 | 1.64 | 81.2 | Adjuvant (A) | 2014-11-30 | 2014-12-26 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 320019736 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320006546 | 320003827 | 1.7 | 63.6 | Curative (C) | 2018-03-29 | 2018-06-27 | Capecitabine + Oxaliplatin 14day | N | Y | 320019736 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320006547 | 320003832 | 1.86 | 87.2 | Palliative (P) | 2014-01-25 | 2014-02-15 | NIVOLUMAB | N | Y | 320019920 | CARBOPLATIN + CETUXIMAB + FU |
| 320006548 | 320005756 | 1.73 | 78.4 | Curative (C) | 2014-05-03 | 2014-07-09 | CYCLOPHOSPHAMIDE + VINORELBINE | null | null | 320019949 | CAPECITABINE + CISPLATIN |
| 320006549 | 320003834 | 1.65 | 88.8 | Palliative (P) | 2014-02-14 | 2014-02-15 | Cetuximab + Radiotherapy Load | 02 | N | 320019969 | RMS 2005 TRIAL |
| 320006552 | 320003840 | 1.62 | 75 | Palliative (P) | 2014-04-09 | 2014-05-01 | Bevacizumab+Carbo+Pacliaxel | 02 | null | 320020064 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320006553 | 320003843 | 1.65 | 83.5 | Palliative (P) | 2012-01-30 | 2013-10-29 | GEMCITABINE | N | N | 320020195 | EURO-EWING |